<DOC>
	<DOCNO>NCT01068028</DOCNO>
	<brief_summary>The purpose study evaluate safety tolerability multiple ascend dos ORM-12741 .</brief_summary>
	<brief_title>Safety Pharmacokinetic Study With Multiple Ascending Doses ORM-12741</brief_title>
	<detailed_description>The purpose evaluate safety , tolerability pharmacokinetics escalate multiple dos ORM-12741 healthy volunteer .</detailed_description>
	<criteria>Good general health ascertain detailed medical history physical examination . Males 18 45 year ( inclusive ) . Body mass index ( BMI ) 1830 kg/m2 inclusive ( BMI = weight/height2 ) . Weight 55100 kg ( inclusive ) . Evidence clinically significant cardiovascular , renal , hepatic , haematological , gastrointestinal , pulmonary , metabolicendocrine , neurological , urogenital psychiatric disease judge investigator . Any condition require regular concomitant medication include herbal product likely need concomitant medication study . Susceptibility severe allergic reaction . Regular consumption 14 unit alcohol per week ( 1 unit = 4 cl spirit , 13 g alcohol ) . Current use nicotinecontaining product 5 cigarette equivalent/day . Inability refrain use nicotinecontaining product stay study centre . Inability refrain consume caffeinecontaining beverage stay study centre e.g . propensity get headache refrain caffeinecontaining beverage . Blood donation loss significant amount blood within 3 month prior screen visit . Abnormal find ECG , vital sign , laboratory test physical examination . Intake investigational compound within 3 month prior start study earlier participation clinical study ORM12741</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>Healthy volunteer study</keyword>
</DOC>